Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
The Journal of Clinical Psychiatry
|
February 12, 2005
Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder
Jaspreet S Brar, Rohan Ganguli, Gahan Pandina, et al.
BMC Medicine
|
July 2, 2008
Assessment of strategies for switching patients from olanzapine to risperidone: a randomized, open-label, rater-blinded study
Rohan Ganguli, Jaspreet S Brar, Ramy Mahmoud, et al.
International Psychogeriatrics
|
October 6, 2005
Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics
Sanford Finkel, Chris Kozma, Stacey Long, et al.
Multiple Sclerosis and Related Disorders
|
March 3, 2019
Vitamin D and body mass index in Egyptian multiple sclerosis patients
Dina Zamzam, Mohamed Foad, Mahmoud Swelam, et al.
Bipolar Disorders
|
November 20, 2009
A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently
Wayne Macfadden, Larry Alphs, J Thomas Haskins, et al.
Gastroenterology Research
|
September 21, 2022
Transnasal Endoscopy for Children and Adolescents With Eosinophilic Esophagitis: A Single-Center Experience
Ramy Mahmoud Mohamed Sabe, Alaa Elzayat, Andrew Buckley, et al.
Psychopharmacology Bulletin
|
September 10, 2008
Psychometric evaluation of a patient-rated troubling symptom scale for generalized anxiety disorder clinical trials
Gahan J Pandina, Dennis A Revicki, Leah Kleinman, et al.
The Journal of Clinical Psychiatry
|
January 24, 2006
Methodological issues in a comparative study of ziprasidone and risperidone
Georges M Gharabawi, Cynthia A Bossie, Ramy Mahmoud, et al.
Journal of Affective Disorders
|
March 27, 2009
Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial
Gahan J Pandina, Dennis A Revicki, Leah Kleinman, et al.
The American Journal of Psychiatry
|
May 5, 2009
Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia
Carla M Canuso, Bryan Dirks, Jennifer Carothers, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
The Journal of Clinical Psychiatry
|
February 12, 2005
Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder
Jaspreet S Brar, Rohan Ganguli, Gahan Pandina, et al.
BMC Medicine
|
July 2, 2008
Assessment of strategies for switching patients from olanzapine to risperidone: a randomized, open-label, rater-blinded study
Rohan Ganguli, Jaspreet S Brar, Ramy Mahmoud, et al.
International Psychogeriatrics
|
October 6, 2005
Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics
Sanford Finkel, Chris Kozma, Stacey Long, et al.
Multiple Sclerosis and Related Disorders
|
March 3, 2019
Vitamin D and body mass index in Egyptian multiple sclerosis patients
Dina Zamzam, Mohamed Foad, Mahmoud Swelam, et al.
Bipolar Disorders
|
November 20, 2009
A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently
Wayne Macfadden, Larry Alphs, J Thomas Haskins, et al.
Gastroenterology Research
|
September 21, 2022
Transnasal Endoscopy for Children and Adolescents With Eosinophilic Esophagitis: A Single-Center Experience
Ramy Mahmoud Mohamed Sabe, Alaa Elzayat, Andrew Buckley, et al.
Psychopharmacology Bulletin
|
September 10, 2008
Psychometric evaluation of a patient-rated troubling symptom scale for generalized anxiety disorder clinical trials
Gahan J Pandina, Dennis A Revicki, Leah Kleinman, et al.
The Journal of Clinical Psychiatry
|
January 24, 2006
Methodological issues in a comparative study of ziprasidone and risperidone
Georges M Gharabawi, Cynthia A Bossie, Ramy Mahmoud, et al.
Journal of Affective Disorders
|
March 27, 2009
Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial
Gahan J Pandina, Dennis A Revicki, Leah Kleinman, et al.
The American Journal of Psychiatry
|
May 5, 2009
Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia
Carla M Canuso, Bryan Dirks, Jennifer Carothers, et al.
Page
of 3